skip to main content

Genomic marker of chemotherapy sensitivity in triple negative breast cancer

Identifiers: SRA: SRP063902
BioProject: PRJNA296425
Study Type: 
Whole Genome Sequencing
Abstract: The purpose of this study was to identify genomic differences between triple-negative breast cancers (TNBC) sensitive and resistant to taxane-containing chemotherapy through whole exome sequencing and to assess measures of genome heterogeneity as predictive markers.

Related SRA data

Experiments:
64 ( 64 samples )
Runs:
64 (449.7Gbp; 297.2Gb)